Promoted channel

ClinScriptum
@clinscriptum
AI-ассистент для клинической и регуляторной документации
Ad info
Impressions by day
37 active daysClinScriptum
Advertiser: @clinscriptum
Days active: 41Last seen: 5d ago
Mini AppCreative
H0 и критерий non-inferiority противоречат друг другу. ClinScriptum обнаружил ошибку при QC протокола. Посмотрите реальную находку.
- CTA button
- POSTNI KOʻRISH
- Reportable
- Yes
Where this ad ran
Top channels by impression count.
Медицинская терминология и полезные ресурсы для переводчиков, писателей и врачей@mymedpharminfo · 1,026 members144placements
Разработка и Регистрация ЛС | международный фарм.журнал@pharmjournal · 1,607 members112placements
Российская фарма@pharma_imr · 1,136 members71placements
Headway Company@headwaypharma · 1,580 members32placements
ФарСмацевтика | Анна Тихонова@farsmacevtika · 2,788 members22placements
Фармвестник@pharmvestnik · 8,864 members13placements
Алло, это фарма?@pharmfm5placements
GхP News@gxpnews4placements
More from this advertiser · @clinscriptum
Research from the blog
- 2026-09-23
Russia's Telegram Ad Market in 2026 in Numbers: ERIR, Mediascope, CPM and Our Archive
Telegram ad budgets in Russia fell 22% per the official ad register, the audience shrank and CPM dropped 41%, yet placements grew. A short summary of 2026 public figures for the Russian Telegram ad market plus what our archive of 585,000 ads shows.
- 2026-09-23
Telegram Ads in Russia in 2026: the FAS Ban, the Moratorium to 31 December and What to Do Now
Russia's antimonopoly regulator treats advertising in Telegram as illegal but will not penalise it until 31 December 2026. A short guide for international readers: timeline, fines, what the moratorium does not cover and a checklist.
